<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29353237</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-330X</ISSN><JournalIssue CitedMedium="Internet"><Volume>89</Volume><Issue>8</Issue><PubDate><Year>2018</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of neurology, neurosurgery, and psychiatry</Title><ISOAbbreviation>J Neurol Neurosurg Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Beyond motor neurons: expanding the clinical spectrum in Kennedy's disease.</ArticleTitle><Pagination><StartPage>808</StartPage><EndPage>812</EndPage><MedlinePgn>808-812</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/jnnp-2017-316961</ELocationID><Abstract><AbstractText>Kennedy's disease, or spinal and bulbar muscular atrophy (SBMA), is an X-linked neuromuscular condition clinically characterised by weakness, atrophy and fasciculations of the limb and bulbar muscles, as a result of lower motor neuron degeneration. The disease is caused by an abnormally expanded triplet repeat expansions in the ubiquitously expressed androgen receptor gene, through mechanisms which are not entirely elucidated. Over the years studies from both humans and animal models have highlighted the involvement of cell populations other than motor neurons in SBMA, widening the disease phenotype. The most compelling aspect of these findings is their potential for therapeutic impact: muscle, for example, which is primarily affected in the disease, has been recently shown to represent a valid alternative target for therapy to motor neurons. In this review, we discuss the emerging study of the extra-motor neuron involvement in SBMA, which, besides increasingly pointing towards a multidisciplinary approach for affected patients, deepens our understanding of the pathogenic mechanisms and holds potential for providing new therapeutic targets for this disease.</AbstractText><CopyrightInformation>&#xa9; Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Manzano</LastName><ForeName>Raquel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorar&#xfa;</LastName><ForeName>Gianni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Neuromuscular Center, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grunseich</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fratta</LastName><ForeName>Pietro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuccaro</LastName><ForeName>Emanuela</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pennuto</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dulbecco Telethon Institute, Centre for Integrative Biology, University of Trento, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rinaldi</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>205162/Z/16/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>FRATTA/JAN15/946-795</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/M008606/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neurol Neurosurg Psychiatry</MedlineTA><NlmUniqueID>2985191R</NlmUniqueID><ISSNLinking>0022-3050</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001342" MajorTopicYN="N">Autonomic Nervous System Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009133" MajorTopicYN="N">Muscular Atrophy</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019680" MajorTopicYN="N">Trinucleotide Repeat Expansion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001748" MajorTopicYN="N">Urinary Bladder Neck Obstruction</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">motor neuron disease</Keyword><Keyword MajorTopicYN="N">neurogenetics</Keyword><Keyword MajorTopicYN="N">neuromuscular</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29353237</ArticleId><ArticleId IdType="pmc">PMC6204939</ArticleId><ArticleId IdType="doi">10.1136/jnnp-2017-316961</ArticleId><ArticleId IdType="pii">jnnp-2017-316961</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>La Spada AR, Wilson EM, Lubahn DB, et al. . Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991;352:77&#x2013;9. 10.1038/352077a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/352077a0</ArticleId><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes LE, Freeman BK, Auh S, et al. . Clinical features of spinal and bulbar muscular atrophy. Brain 2009;132:3242&#x2013;51. 10.1093/brain/awp258</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp258</ArticleId><ArticleId IdType="pmc">PMC2792370</ArticleId><ArticleId IdType="pubmed">19846582</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumner CJ, Fischbeck KH. Jaw drop in Kennedy&#x2019;s disease. Neurology 2002;59:1471&#x2013;2. 10.1212/01.WNL.0000033325.01878.13</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000033325.01878.13</ArticleId><ArticleId IdType="pubmed">12427914</ArticleId></ArticleIdList></Reference><Reference><Citation>Atsuta N, Watanabe H, Ito M, et al. . Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain 2006;129(Pt 6):1446&#x2013;55. 10.1093/brain/awl096</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl096</ArticleId><ArticleId IdType="pubmed">16621916</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Rhodes LE, Kokkinis AD, White MJ, et al. . Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial. Lancet Neurol 2011;10:140&#x2013;7. 10.1016/S1474-4422(10)70321-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70321-5</ArticleId><ArticleId IdType="pmc">PMC3056353</ArticleId><ArticleId IdType="pubmed">21216197</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangelsdorf DJ, Thummel C, Beato M, et al. . The nuclear receptor superfamily: the second decade. Cell 1995;83:835&#x2013;9. 10.1016/0092-8674(95)90199-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(95)90199-X</ArticleId><ArticleId IdType="pmc">PMC6159888</ArticleId><ArticleId IdType="pubmed">8521507</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinkmann AO. Molecular basis of androgen insensitivity. Mol Cell Endocrinol 2001;179:105&#x2013;9. 10.1016/S0303-7207(01)00466-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0303-7207(01)00466-X</ArticleId><ArticleId IdType="pubmed">11420135</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennuto M, Rinaldi C. From gene to therapy in spinal and bulbar muscular atrophy: are we there yet? Mol Cell Endocrinol 2017;S0303-7207:30359&#x2013;3. 10.1016/j.mce.2017.07.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2017.07.005</ArticleId><ArticleId IdType="pubmed">28688959</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti A. The polyglutamine tract of androgen receptor: from functions to dysfunctions in motor neurons. Front Neuroendocrinol 2004;25:1&#x2013;26. 10.1016/j.yfrne.2004.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yfrne.2004.03.001</ArticleId><ArticleId IdType="pubmed">15183036</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Chevalier-Larsen ES, Merry DE, et al. . Soluble androgen receptor oligomers underlie pathology in a mouse model of spinobulbar muscular atrophy. J Biol Chem 2007;282:3157&#x2013;64. 10.1074/jbc.M609972200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M609972200</ArticleId><ArticleId IdType="pubmed">17121819</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusmini P, Sau D, Crippa V, et al. . Aggregation and proteasome: the case of elongated polyglutamine aggregation in spinal and bulbar muscular atrophy. Neurobiol Aging 2007;28:1099&#x2013;111. 10.1016/j.neurobiolaging.2006.05.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2006.05.015</ArticleId><ArticleId IdType="pubmed">16781019</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi H, Katsuno M, Minamiyama M, et al. . Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. Brain 2005;128:659&#x2013;70. 10.1093/brain/awh381</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh381</ArticleId><ArticleId IdType="pubmed">15659427</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka K, Matsuda N. Proteostasis and neurodegeneration: the roles of proteasomal degradation and autophagy. Biochim Biophys Acta 2014;1843:197&#x2013;204. 10.1016/j.bbamcr.2013.03.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2013.03.012</ArticleId><ArticleId IdType="pubmed">23523933</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldi C, M&#xe4;ger I, Wood MJ. Proteostasis and Diseases of the Motor Unit. Front Mol Neurosci 2016;9:164 10.3389/fnmol.2016.00164</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00164</ArticleId><ArticleId IdType="pmc">PMC5187379</ArticleId><ArticleId IdType="pubmed">28082869</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Shin JH, Park KP, et al. . Phenotypic variability in Kennedy&#x2019;s disease: implication of the early diagnostic features. Acta Neurol Scand 2005;112:57&#x2013;63. 10.1111/j.1600-0404.2005.00428.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2005.00428.x</ArticleId><ArticleId IdType="pubmed">15932358</ArticleId></ArticleIdList></Reference><Reference><Citation>Chahin N, Sorenson EJ. Serum creatine kinase levels in spinobulbar muscular atrophy and amyotrophic lateral sclerosis. Muscle Nerve 2009;40:126&#x2013;9. 10.1002/mus.21310</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21310</ArticleId><ArticleId IdType="pubmed">19533663</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorar&#xf9; G, D&#x2019;Ascenzo C, Polo A, et al. . Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. J Neurol Sci 2008;264:100&#x2013;5. 10.1016/j.jns.2007.08.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2007.08.012</ArticleId><ArticleId IdType="pubmed">17854832</ArticleId></ArticleIdList></Reference><Reference><Citation>Malena A, Pennuto M, Tezze C, et al. . Androgen-dependent impairment of myogenesis in spinal and bulbar muscular atrophy. Acta Neuropathol 2013;126:109&#x2013;21. 10.1007/s00401-013-1122-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1122-9</ArticleId><ArticleId IdType="pubmed">23644820</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazzolo I, Stack C, Kong L, et al. . Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron 2009;63:316&#x2013;28. 10.1016/j.neuron.2009.07.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2009.07.019</ArticleId><ArticleId IdType="pmc">PMC2735765</ArticleId><ArticleId IdType="pubmed">19679072</ArticleId></ArticleIdList></Reference><Reference><Citation>Sambataro F, Pennuto M. Cell-autonomous and non-cell-autonomous toxicity in polyglutamine diseases. Prog Neurobiol 2012;97:152&#x2013;72. 10.1016/j.pneurobio.2011.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2011.10.003</ArticleId><ArticleId IdType="pubmed">22061202</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, Dadgar N, Albertelli M, et al. . Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J Clin Invest 2006;116:2663&#x2013;72. 10.1172/JCI28773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI28773.</ArticleId><ArticleId IdType="pmc">PMC1564432</ArticleId><ArticleId IdType="pubmed">16981011</ArticleId></ArticleIdList></Reference><Reference><Citation>Monks DA, Johansen JA, Mo K, et al. . Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc Natl Acad Sci U S A 2007;104:18259&#x2013;64. 10.1073/pnas.0705501104</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0705501104</ArticleId><ArticleId IdType="pmc">PMC2084330</ArticleId><ArticleId IdType="pubmed">17984063</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes CJ, Ling SC, Guo LT, et al. . Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy. Neuron 2014;82:295&#x2013;307. 10.1016/j.neuron.2014.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.03.001</ArticleId><ArticleId IdType="pmc">PMC4096235</ArticleId><ArticleId IdType="pubmed">24742458</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman AP, Yu Z, Murray S, et al. . Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy. Cell Rep 2014;7:774&#x2013;84. 10.1016/j.celrep.2014.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.02.008</ArticleId><ArticleId IdType="pmc">PMC4356525</ArticleId><ArticleId IdType="pubmed">24746732</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldi C, Bott L, et al. . Insulinlike growth factor (IGF)-1 administration ameliorates disease manifestations in a mouse model of spinal and bulbar muscular atrophy. Mol Med 2012;18:1&#x2013;8. 10.2119/molmed.2012.00271</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2012.00271</ArticleId><ArticleId IdType="pmc">PMC3521783</ArticleId><ArticleId IdType="pubmed">22952056</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada S, Hashizume A, Hijikata Y, et al. . Decreased peak expiratory flow associated with muscle fiber-type switching in spinal and bulbar muscular atrophy. PLoS One 2016;11:e0168846 10.1371/journal.pone.0168846</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0168846</ArticleId><ArticleId IdType="pmc">PMC5179045</ArticleId><ArticleId IdType="pubmed">28005993</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocchi A, Milioto C, Parodi S, et al. . Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet. Acta Neuropathol 2016;132:127&#x2013;44. 10.1007/s00401-016-1550-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1550-4</ArticleId><ArticleId IdType="pmc">PMC4911374</ArticleId><ArticleId IdType="pubmed">26971100</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariotti C, Castellotti B, Pareyson D, et al. . Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families. Neuromuscul Disord 2000;10:391&#x2013;7. 10.1016/S0960-8966(99)00132-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-8966(99)00132-7</ArticleId><ArticleId IdType="pubmed">10899444</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P, Nirmalananthan N, Masset L, et al. . Correlation of clinical and molecular features in spinal bulbar muscular atrophy. Neurology 2014;82:2077&#x2013;84. 10.1212/WNL.0000000000000507</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000507</ArticleId><ArticleId IdType="pmc">PMC4075620</ArticleId><ArticleId IdType="pubmed">24814851</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobue G, Hashizume Y, Mukai E, et al. . X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain 1989;112(Pt 1):209&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">2917278</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki K, Katsuno M, Banno H, et al. . CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. Brain 2008;131:229&#x2013;39. 10.1093/brain/awm289</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awm289</ArticleId><ArticleId IdType="pubmed">18056738</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes LE, Freeman BK, Auh S, et al. . Clinical features of spinal and bulbar muscular atrophy. Brain 2009;132(Pt 12):3242&#x2013;51. 10.1093/brain/awp258</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp258</ArticleId><ArticleId IdType="pmc">PMC2792370</ArticleId><ArticleId IdType="pubmed">19846582</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni W, Chen S, Qiao K, et al. . Genotype-phenotype correlation in Chinese patients with spinal and bulbar muscular atrophy. PLoS One 2015;10:e0122279 10.1371/journal.pone.0122279</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0122279</ArticleId><ArticleId IdType="pmc">PMC4374859</ArticleId><ArticleId IdType="pubmed">25811990</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Sobue G, Doyu M, et al. . Primary sensory neurons in X-linked recessive bulbospinal neuropathy: histopathology and androgen receptor gene expression. Muscle Nerve 1995;18:301&#x2013;8. 10.1002/mus.880180306</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880180306</ArticleId><ArticleId IdType="pubmed">7870107</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Lim YM, Lee EJ, et al. . Correlation between the CAG repeat size and electrophysiological findings in patients with spinal and bulbar muscular atrophy. Muscle Nerve 2017. [Epub ahead of print 3 Oct 2017]. 10.1002/mus.25977</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25977</ArticleId><ArticleId IdType="pubmed">28972672</ArticleId></ArticleIdList></Reference><Reference><Citation>Manganelli F, Iodice V, Provitera V, et al. . Small-fiber involvement in spinobulbar muscular atrophy (Kennedy&#x2019;s disease). Muscle Nerve 2007;36:816&#x2013;20. 10.1002/mus.20872</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20872</ArticleId><ArticleId IdType="pubmed">17691102</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonini G, Gragnani F, Romaniello A, et al. . Sensory involvement in spinal-bulbar muscular atrophy (Kennedy&#x2019;s disease). Muscle Nerve 2000;23:252&#x2013;8. 10.1002/(SICI)1097-4598(200002)23:2&lt;252::AID-MUS17&gt;3.0.CO;2-P</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4598(200002)23:2&lt;252::AID-MUS17&gt;3.0.CO;2-P</ArticleId><ArticleId IdType="pubmed">10639619</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocchi C, Greco V, Urbani A, et al. . Subclinical autonomic dysfunction in spinobulbar muscular atrophy (Kennedy disease). Muscle Nerve 2011;44:737&#x2013;40. 10.1002/mus.22159</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.22159</ArticleId><ArticleId IdType="pubmed">22006688</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunseich C, Kats IR, Bott LC, et al. . Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat. Neuromuscul Disord 2014;24:978&#x2013;81. 10.1016/j.nmd.2014.06.441</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2014.06.441</ArticleId><ArticleId IdType="pmc">PMC4252652</ArticleId><ArticleId IdType="pubmed">25047668</ArticleId></ArticleIdList></Reference><Reference><Citation>Pachatz C, Terracciano C, Desiato MT, et al. . Upper motor neuron involvement in X-linked recessive bulbospinal muscular atrophy. Clin Neurophysiol 2007;118:262&#x2013;8. 10.1016/j.clinph.2006.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2006.10.006</ArticleId><ArticleId IdType="pubmed">17137837</ArticleId></ArticleIdList></Reference><Reference><Citation>Unrath A, M&#xfc;ller HP, Riecker A, et al. . Whole brain-based analysis of regional white matter tract alterations in rare motor neuron diseases by diffusion tensor imaging. Hum Brain Mapp 2010;31:1727&#x2013;40. 10.1002/hbm.20971</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.20971</ArticleId><ArticleId IdType="pmc">PMC6871219</ArticleId><ArticleId IdType="pubmed">20336652</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai TH, Liu RS, Yang BH, et al. . Cerebral involvement in spinal and bulbar muscular atrophy (Kennedy&#x2019;s disease): a pilot study of PET. J Neurol Sci 2013;335:139&#x2013;44. 10.1016/j.jns.2013.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2013.09.016</ArticleId><ArticleId IdType="pubmed">24120273</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Rosa E, Sorar&#xf9; G, Kleinbub JR, et al. . Theory of mind, empathy and neuropsychological functioning in X-linked spinal and bulbar muscular atrophy: a controlled study of 20 patients. J Neurol 2015;262:394&#x2013;401. 10.1007/s00415-014-7567-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-014-7567-5</ArticleId><ArticleId IdType="pubmed">25408365</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G, Bertolin C, Da Re E, et al. . Non-neural phenotype of spinal and bulbar muscular atrophy: results from a large cohort of Italian patients. J Neurol Neurosurg Psychiatry 2016;87:810&#x2013;6. 10.1136/jnnp-2015-311305</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-311305</ArticleId><ArticleId IdType="pmc">PMC4975824</ArticleId><ArticleId IdType="pubmed">26503015</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakatsuji H, Araki A, Hashizume A, et al. . Correlation of insulin resistance and motor function in spinal and bulbar muscular atrophy. J Neurol 2017;264:839&#x2013;47. 10.1007/s00415-017-8405-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-017-8405-3</ArticleId><ArticleId IdType="pubmed">28229243</ArticleId></ArticleIdList></Reference><Reference><Citation>Guber RD, Takyar V, Kokkinis A, et al. . Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophy. Neurology 2017;89:2481&#x2013;90. 10.1212/WNL.0000000000004748</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004748</ArticleId><ArticleId IdType="pmc">PMC5729799</ArticleId><ArticleId IdType="pubmed">29142082</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashizume A, Katsuno M, Banno H, et al. . Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy. Brain 2012;135:2838&#x2013;48. 10.1093/brain/aws170</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws170</ArticleId><ArticleId IdType="pubmed">22773541</ArticleId></ArticleIdList></Reference><Reference><Citation>Hijikata Y, Katsuno M, Suzuki K, et al. . Impaired muscle uptake of creatine in spinal and bulbar muscular atrophy. Ann Clin Transl Neurol 2016;3:537&#x2013;46. 10.1002/acn3.324</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.324</ArticleId><ArticleId IdType="pmc">PMC4931718</ArticleId><ArticleId IdType="pubmed">27386502</ArticleId></ArticleIdList></Reference><Reference><Citation>Araki A, Katsuno M, Suzuki K, et al. . Brugada syndrome in spinal and bulbar muscular atrophy. Neurology 2014;82:1813&#x2013;21. 10.1212/WNL.0000000000000434</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000434</ArticleId><ArticleId IdType="pubmed">24759840</ArticleId></ArticleIdList></Reference><Reference><Citation>Naseef A, Behr ER, Batchvarov VN. Electrocardiographic methods for diagnosis and risk stratification in the Brugada syndrome. J Saudi Heart Assoc 2015;27:96&#x2013;108. 10.1016/j.jsha.2014.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsha.2014.06.004</ArticleId><ArticleId IdType="pmc">PMC4392351</ArticleId><ArticleId IdType="pubmed">25870503</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>